Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew W D Perry

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|December 25, 2018
Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune DiseasesMatthew W D Perry, Raolat Abdulai, Mickael Mogemark, et al.
The Journal of Biological Chemistry|March 21, 2021
Glucocorticoid receptor Thr524 phosphorylation by MINK1 induces interactions with 14-3-3 protein regulatorsClaire C Munier, Leonardo De Maria, Karl Edman, et al.
Expert Opinion on Drug Discovery|July 12, 2017
Stabilization of protein-protein interactions in drug discoverySebastian A Andrei, Eline Sijbesma, Michael Hann, et al.
ACS Chemical Biology|March 7, 2020
Identification of Phosphate-Containing Compounds as New Inhibitors of 14-3-3/c-Abl Protein-Protein InteractionLeire Iralde-Lorente, Giusy Tassone, Letizia Clementi, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2012
The discovery of CCR3/H1 dual antagonists with reduced hERG riskAsh Bahl, Patrick Barton, Keith Bowers, et al.
Journal of Medicinal Chemistry|February 15, 2014
Impact of stereospecific intramolecular hydrogen bonding on cell permeability and physicochemical propertiesBjörn Over, Patrick McCarren, Per Artursson, et al.
Journal of Medicinal Chemistry|December 9, 2022
Designing Selective Drug-like Molecular Glues for the Glucocorticoid Receptor/14-3-3 Protein-Protein InteractionJakob S Pallesen, Claire C Munier, Francesco Bosica, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2012
Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092Ash Bahl, Patrick Barton, Keith Bowers, et al.
Nature Chemical Biology|February 6, 2019
A class of highly selective inhibitors bind to an active state of PI3KγGangadhara Gangadhara, Göran Dahl, Thomas Bohnacker, et al.
Nature Chemical Biology|October 25, 2016
Structural and conformational determinants of macrocycle cell permeabilityBjörn Over, Pär Matsson, Christian Tyrchan, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|December 25, 2018
Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune DiseasesMatthew W D Perry, Raolat Abdulai, Mickael Mogemark, et al.
The Journal of Biological Chemistry|March 21, 2021
Glucocorticoid receptor Thr524 phosphorylation by MINK1 induces interactions with 14-3-3 protein regulatorsClaire C Munier, Leonardo De Maria, Karl Edman, et al.
Expert Opinion on Drug Discovery|July 12, 2017
Stabilization of protein-protein interactions in drug discoverySebastian A Andrei, Eline Sijbesma, Michael Hann, et al.
ACS Chemical Biology|March 7, 2020
Identification of Phosphate-Containing Compounds as New Inhibitors of 14-3-3/c-Abl Protein-Protein InteractionLeire Iralde-Lorente, Giusy Tassone, Letizia Clementi, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2012
The discovery of CCR3/H1 dual antagonists with reduced hERG riskAsh Bahl, Patrick Barton, Keith Bowers, et al.
Journal of Medicinal Chemistry|February 15, 2014
Impact of stereospecific intramolecular hydrogen bonding on cell permeability and physicochemical propertiesBjörn Over, Patrick McCarren, Per Artursson, et al.
Journal of Medicinal Chemistry|December 9, 2022
Designing Selective Drug-like Molecular Glues for the Glucocorticoid Receptor/14-3-3 Protein-Protein InteractionJakob S Pallesen, Claire C Munier, Francesco Bosica, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2012
Scaffold-hopping with zwitterionic CCR3 antagonists: identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092Ash Bahl, Patrick Barton, Keith Bowers, et al.
Nature Chemical Biology|February 6, 2019
A class of highly selective inhibitors bind to an active state of PI3KγGangadhara Gangadhara, Göran Dahl, Thomas Bohnacker, et al.
Nature Chemical Biology|October 25, 2016
Structural and conformational determinants of macrocycle cell permeabilityBjörn Over, Pär Matsson, Christian Tyrchan, et al.
Pageof 3